DNA Sequencing Market Research Reports & Industry Analysis
DNA sequencing is a fast-growing market that contributes to various fields such as healthcare, agriculture, and forensics. Many of the world’s most innovative life sciences companies use DNA sequencing technologies to develop novel products and treatments. To help you stay informed in this rapidly evolving landscape, MarketResearch.com offers an array of DNA sequencing industry reports packed with data and expert analysis.
DNA Sequencing Market Size Data
- We bring together comprehensive and reliable research from a variety of expert analysts to help save you valuable time.
- Search our collection to quickly find information on DNA sequencing market size, segmentation, the competitive landscape, and leading vendors.
- Learn about new technological advancements, disruptive trends, and other hot topics.
Your Research Partner
For more than twenty years, MarketResearch.com has assisted clients worldwide in making informed business decisions. We serve investment banks, management consulting firms, major Fortune 500 companies, and leading life science firms. Our team of research specialists is here to guide you through this information-rich landscape. From your initial questions to the final stages of your research, we are ready to offer tailored suggestions and ongoing support.
DNA Sequencing Industry Research & Market Reports
-
Gene Panel
... CAGR of 19.7% over the analysis period 2024-2030. Cancer Risk Assessment, one of the segments analyzed in the report, is expected to record a 21.2% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
DNA Sequencing
... CAGR of 11.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. ... Read More
-
Metagenomic Sequencing
... CAGR of 17.6% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.4% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Biotechnology Reagents
... CAGR of 4.4% over the analysis period 2024-2030. Chromatography, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
SNP Genotyping and Analysis
... 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. SNP Genotyping by Microarrays and GeneChips, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach ... Read More
-
Short-Read Sequencing
... CAGR of 10.0% over the analysis period 2024-2030. Next-Generation Sequencing, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$25.0 Billion by the end of the analysis ... Read More
-
Lab-on-a-Chip
... 9.4% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.0 Billion by the end of the analysis period. Growth in ... Read More
-
CRISPR Technology
... CAGR of 20.9% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$6.1 Billion by the end of the analysis period. ... Read More
-
Microbial Identification
... CAGR of 11.5% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$5.0 Billion by the end of the analysis period. ... Read More
-
Synthetic Biology
... CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end of ... Read More
-
Plant Breeding and CRISPR Plants
... Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2024-2030. Conventional Breeding, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$16.0 Billion ... Read More
-
FISH Probe
... CAGR of 5.9% over the analysis period 2024-2030. Q-FISH, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$638.3 Million by the end of the analysis period. ... Read More
-
Synthetic Genes
... CAGR of 17.7% over the analysis period 2024-2030. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$9.8 Billion by the end of the ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Next Generation Sequencers
... at a CAGR of 17.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the end of the ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$28.1 Billion by the end of the analysis period. ... Read More
-
Enzymatic DNA Synthesis Market Size, Share & Trends Analysis Report By Service (Oligonucleotide Synthesis, Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering), By End-use, By Region, And Segment)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... growing at a CAGR of 26.5% from 2024 to 2033. Enzymatic DNA Synthesis Market Key Takeaways North America dominated the market and accounted for a 50.81% share in 2023 The enzymatic DNA synthesis market in ... Read More
-
Innovative Medicine Market, By Therapy Type (Immunotherapy, Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule Therapy, Biologic Therapy, RNA-Based Therapy, Progenitor Cell Therapy, Peptide-Based Therapy, Microbiome Therapy, Antisense Oligonucleotide Therapy, CRISPR-based Therapy, mRNA-based Vaccines, and Monoclonal Antibodies), By Application (Oncology, Neurology, Cardiology, Ophthalmology, Dermatology, Musculoskeletal Disorders, Immunology & Inflammation, Genetic Disorders, Infectious Diseases, Metabolic Disorders, Hematology, Rare Diseases, Gastroenterology, and Others), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular, Topical, and Inhalation), By End User (Hospitals & Clinics, Academic & Research Institutes, Specialty Centers, Ambulatory Surgical Centers, Government & Regulatory Bodies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Innovative medicines, also known as specialty drugs or biopharmaceuticals, are advanced medical treatments that offer new and improved therapeutic options for various diseases. These medicines are developed using cutting-edge technologies and are designed to target ... Read More
-
Global Microbiome Sequencing Market
... companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period. This report analyzes the ... Read More
-
2025 Global Forecast for Microbiome Sequencing Services Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
... CAGR driven by its increasing adoption in research, clinical, and industrial applications. Several factors contribute to this market expansion, including the rising prevalence of genetic disorders, the growing use of CRISPR in drug discovery and ... Read More
-
Global Enzymatic DNA Synthesis Market Size study, by Service, Application (Synthetic Biology, Genetic Engineering), End-use, and Regional Forecasts 2022-2032
... next-generation approach to constructing oligonucleotides and genes, is redefining the pace, precision, and sustainability of synthetic biology workflows. By harnessing enzymes to assemble DNA in vitro, this innovative technology circumvents the limitations of traditional phosphoramidite ... Read More
-
Molecular Diagnostics Market Report by Product (Reagents and Kits, Instruments, Software and Services), Technology (Polymerase Chain Reactions (PCR), Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases Diagnostics, Oncology, Genetic Testing, Blood Screening, and Others), End Users (Hospitals, Laboratories, and Others), and Region 2025-2033
... The increasing prevalence of infectious diseases and genetic disorders, technological advancements in polymerase chain reaction (PCR), growing aging population, surging awareness of early disease detection, and supportive government initiatives are factors shaping the market's trajectory. ... Read More
-
Global Human Gene Sequencing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
... a CAGR of %during review period. This report is a detailed and comprehensive analysis for global Human Gene Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type ... Read More
-
2025 Global: Human Microbiome Sequencing Technology Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
Research Assistance
